Principal Financial Group Inc. lowered its stake in Genpact Limited (NYSE:G - Free Report) by 2.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 372,592 shares of the business services provider's stock after selling 7,618 shares during the period. Principal Financial Group Inc. owned approximately 0.21% of Genpact worth $16,003,000 at the end of the most recent reporting period.
A number of other institutional investors have also modified their holdings of G. State of New Jersey Common Pension Fund D purchased a new stake in Genpact during the fourth quarter worth $2,030,000. Principal Securities Inc. raised its holdings in shares of Genpact by 151.6% in the fourth quarter. Principal Securities Inc. now owns 4,380 shares of the business services provider's stock worth $188,000 after acquiring an additional 2,639 shares during the last quarter. Manchester Capital Management LLC acquired a new position in shares of Genpact in the fourth quarter worth $38,000. Van ECK Associates Corp acquired a new position in shares of Genpact in the fourth quarter worth $7,545,000. Finally, SRH Advisors LLC acquired a new position in shares of Genpact in the fourth quarter worth $26,000. Institutional investors and hedge funds own 96.03% of the company's stock.
Analyst Upgrades and Downgrades
Several equities analysts recently commented on G shares. Mizuho upped their target price on Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a research note on Monday, February 10th. TD Cowen upgraded Genpact from a "hold" rating to a "buy" rating and upped their target price for the company from $45.00 to $60.00 in a research note on Friday, February 7th. Needham & Company LLC upped their target price on Genpact from $55.00 to $65.00 and gave the company a "buy" rating in a research note on Friday, February 7th. Jefferies Financial Group upgraded Genpact from a "hold" rating to a "buy" rating and upped their target price for the company from $44.00 to $55.00 in a research note on Tuesday, January 21st. Finally, Robert W. Baird upped their target price on Genpact from $44.00 to $48.00 and gave the company a "neutral" rating in a research note on Friday, November 8th. Six analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $48.44.
View Our Latest Report on Genpact
Insider Transactions at Genpact
In related news, SVP Piyush Mehta sold 12,000 shares of the stock in a transaction dated Friday, January 10th. The stock was sold at an average price of $42.83, for a total value of $513,960.00. Following the completion of the transaction, the senior vice president now owns 151,182 shares of the company's stock, valued at approximately $6,475,125.06. This represents a 7.35 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Balkrishan Kalra sold 13,600 shares of the stock in a transaction dated Friday, December 13th. The shares were sold at an average price of $44.60, for a total value of $606,560.00. Following the completion of the transaction, the chief executive officer now directly owns 267,404 shares of the company's stock, valued at $11,926,218.40. This represents a 4.84 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 2.80% of the company's stock.
Genpact Trading Up 1.0 %
NYSE:G traded up $0.52 on Friday, hitting $53.22. 2,318,410 shares of the stock were exchanged, compared to its average volume of 1,559,439. The stock has a market cap of $9.39 billion, a PE ratio of 18.74, a PEG ratio of 1.84 and a beta of 1.20. The company has a current ratio of 2.16, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50. The stock has a fifty day moving average of $48.00 and a 200-day moving average of $43.38. Genpact Limited has a fifty-two week low of $30.23 and a fifty-two week high of $56.76.
Genpact (NYSE:G - Get Free Report) last issued its earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a return on equity of 22.50% and a net margin of 10.77%. As a group, equities analysts expect that Genpact Limited will post 3.21 earnings per share for the current fiscal year.
Genpact Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Tuesday, March 11th will be given a $0.17 dividend. This is an increase from Genpact's previous quarterly dividend of $0.15. The ex-dividend date is Tuesday, March 11th. This represents a $0.68 annualized dividend and a dividend yield of 1.28%. Genpact's dividend payout ratio is presently 23.94%.
Genpact Company Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Featured Articles

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.